AI assistant
RESMED INC — Director's Dealing 2012
Aug 20, 2012
30071_dirs_2012-08-20_135f1bb7-1385-4e4b-b7fb-0a74c9b05edf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2012-08-15
Reporting Person: FARRELL PETER C (Director, Executive Chairman and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-08-15 | ResMed Common Stock | G | 141160 | — | Disposed | 491736 | Direct |
| 2012-08-15 | ResMed Common Stock | G | 47827 | — | Disposed | 443909 | Direct |
| 2012-08-15 | ResMed Common Stock | G | 24606 | — | Disposed | 419303 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 200000 | Indirect |
| ResMed Common Stock | 200000 | Indirect |
Footnotes
F1: Transaction represents a distribution from the Peter C. Farrell August 2011 Annuity Trust of 178,609 shares to the Peter C. Farrell Trust. Dr. Farrell is the Trustee of his personal trust but is not the Trustee of the Annuity Trust. Per the terms of the Annuity Trust, 90% of the original value was to be transferred to Dr. Farrell at the end of the first year.
F2: Gifted to the Farrell Family Foundation, of which Dr. Farrell is a co-Trustee and has shared voting and dispositive power.
F3: Gifted to the San Diego Foundation (Farrell Fund).